Artificial intelligence for prediction of clinical response and therapeutic value in interventional pain management: a scoping review

• by Mariana González Garcés, Jerónimo Cárdenas Montoya, Valeria Concha Fernández, Mario Andrés Torres Torres, Erwin Hernando Hernández Rincón

• July 2, 2026

Sleep Program Shifted Teen Circadian Timing

Two-week chronotherapy trial evaluates circadian phase, sleep duration, and alignment outcomes.

• by Kathryn Wighton

• May 13, 2026

• 6 min

GLP-1 Drugs Tied to Lower Addiction Risk

In a target-trial emulation of more than 600,000 veterans, GLP-1 RA initiators saw fewer new substance use disorders—and patients with existing SUDs had fewer overdoses, hospitalizations, and deaths.

• by Kathryn Wighton

• May 27, 2026

• 5 min

Caffeine use disorder and analgesic dependence in medication-overuse headache: insights into an underrecognized relationship

• by Rehab Magdy, Amr Hassan, Mona Hussein, Alaa Elmazny, Osama Yacoub, Mohamed Abdelghaffar, Nourhan Abdelmohsen Taha, Ahmed Essmat, May M. Fayez, Nahla Merghany, Anas Elgenidi, Ahmed Dahshan

• July 13, 2026